(Q27026828)

Robert C Murphy

series ordinal

2

1 reference

Mark A Nathan

series ordinal

3

1 reference

Kazuro Sugimura

series ordinal

4

1 reference

language of work or name

1 reference

January 2014

1 reference

International Journal of Urology

published in

1 reference

volume

21

1 reference

issue

1

1 reference

page(s)

12-23

1 reference

The natural history of prostate cancer

cites work

1 reference

Prostate cancer--biology of metastasis and its clinical implications

21 January 2018

1 reference

Prostate cancer: multiparametric MR imaging for detection, localization, and staging.

21 January 2018

1 reference

MR imaging of treated prostate cancer.

21 January 2018

1 reference

Molecular imaging of prostate cancer with 18F-fluorodeoxyglucose PET.

21 January 2018

1 reference

Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer.

21 January 2018

1 reference

Assessment of PET tracer uptake in hormone-independent and hormone-dependent xenograft prostate cancer mouse models

21 January 2018

1 reference

Do androgens control the uptake of 18F-FDG, 11C-choline and 11C-acetate in human prostate cancer cell lines?

21 January 2018

1 reference

Fluorodeoxyglucose positron emission tomography studies in diagnosis and staging of clinically organ-confined prostate cancer

21 January 2018

1 reference

Preoperative detection of prostate cancer: a comparison with 11C-choline PET, 18F-fluorodeoxyglucose PET and MR imaging

21 January 2018

1 reference

EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease

21 January 2018

1 reference

Fluorodeoxyglucose positron emission tomography studies in the diagnosis and staging of clinically advanced prostate cancer

21 January 2018

1 reference

The potential of FDG-PET/CT for detecting prostate cancer in patients with an elevated serum PSA level.

21 January 2018

1 reference

Evaluation of primary prostate cancer using 11C-methionine-PET/CT and 18F-FDG-PET/CT.

21 January 2018

1 reference

Relationship between cancer type and impact of PET and PET/CT on intended management: findings of the national oncologic PET registry

21 January 2018

1 reference

Prognostic value of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography imaging for patients with prostate cancer

21 January 2018

1 reference

Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer

21 January 2018

1 reference

Prognostic value of baseline [18F] fluorodeoxyglucose positron emission tomography and 99mTc-MDP bone scan in progressing metastatic prostate cancer

21 January 2018

1 reference

Detecting Metastatic Pelvic Lymph Nodes by <sup>18</sup>F-2-Deoxyglucose Positron Emission Tomography in Patients with Prostate-Specific Antigen Relapse after Treatment for Localized Prostate Cancer

21 January 2018

1 reference

Positron emission tomography with 11C-acetate and 18F-FDG in prostate cancer patients

21 January 2018

1 reference

Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography.

21 January 2018

1 reference

2-[18F]fluoro-2-deoxyglucose positron emission tomography for the detection of disease in patients with prostate-specific antigen relapse after radical prostatectomy

21 January 2018

1 reference

Dual tracer 11C-choline and FDG-PET in the diagnosis of biochemical prostate cancer relapse after radical treatment.

21 January 2018

1 reference

Prospective evaluation of 18F-NaF and 18F-FDG PET/CT in detection of occult metastatic disease in biochemical recurrence of prostate cancer

21 January 2018

1 reference

FDG PET for evaluating the change of glucose metabolism in prostate cancer after androgen ablation.

21 January 2018

1 reference

Fluorodeoxyglucose positron emission tomography as an outcome measure for castrate metastatic prostate cancer treated with antimicrotubule chemotherapy.

21 January 2018

1 reference

Characterization of acetate metabolism in tumor cells in relation to cell proliferation: acetate metabolism in tumor cells.

21 January 2018

1 reference

Accumulation of [11C]acetate in normal prostate and benign prostatic hyperplasia: comparison with prostate cancer

21 January 2018

1 reference

Functional imaging of localized prostate cancer aggressiveness using 11C-acetate PET/CT and 1H-MR spectroscopy.

21 January 2018

1 reference

11C-Acetate PET/CT in localized prostate cancer: a study with MRI and histopathologic correlation

21 January 2018

1 reference

Carbon-11 acetate positron emission tomography can detect local recurrence of prostate cancer

21 January 2018

1 reference

11C-acetate positron emission tomography imaging and image fusion with computed tomography and magnetic resonance imaging in patients with recurrent prostate cancer.

21 January 2018

1 reference

(11)C-acetate PET in the early evaluation of prostate cancer recurrence.

21 January 2018

1 reference

18F-choline and/or 11C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (<1 ng/mL) after radical prostatectomy.

21 January 2018

1 reference

C11-acetate and F-18 FDG PET for men with prostate cancer bone metastases: relative findings and response to therapy

21 January 2018

1 reference

Choline phospholipid metabolism: a target in cancer cells?

21 January 2018

1 reference

Prostate cancer: a comparative study of 11C-choline PET and MR imaging combined with proton MR spectroscopy

21 January 2018

1 reference

11C-choline positron emission tomography/computerized tomography for tumor localization of primary prostate cancer in comparison with 12-core biopsy.

21 January 2018

1 reference

Value of 11C-choline PET and PET/CT in patients with suspected prostate cancer

21 January 2018

1 reference

Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT.

21 January 2018

1 reference

[(11)C]choline uptake with PET/CT for the initial diagnosis of prostate cancer: relation to PSA levels, tumour stage and anti-androgenic therapy

21 January 2018

1 reference

Is there an additional value of ¹¹C-choline PET-CT to T2-weighted MRI images in the localization of intraprostatic tumor nodules?

21 January 2018

1 reference

The sensitivity of [11C]choline PET/CT to localize prostate cancer depends on the tumor configuration.

21 January 2018

1 reference

Detection of aggressive primary prostate cancer with 11C-choline PET/CT using multimodality fusion techniques

21 January 2018

1 reference

Prostate cancer localization with 18fluorine fluorocholine positron emission tomography.

21 January 2018

1 reference

Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer.

21 January 2018

1 reference

The value of 18F-choline PET/CT in patients with elevated PSA-level and negative prostate needle biopsy for localisation of prostate cancer

21 January 2018

1 reference

18F choline PET/CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients

21 January 2018

1 reference

[18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.

21 January 2018

1 reference

Choline PET/CT for imaging prostate cancer: an update

21 January 2018

1 reference

The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis

21 January 2018

1 reference

11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms

21 January 2018

1 reference

Use of [11C]choline PET-CT as a noninvasive method for detecting pelvic lymph node status from prostate cancer and relationship with choline kinase expression.

21 January 2018

1 reference

Detection of pelvic lymph node metastases in patients with clinically localized prostate cancer: comparison of [18F]fluorocholine positron emission tomography-computerized tomography and laparoscopic radioisotope guided sentinel lymph node dissectio

21 January 2018

1 reference

[F(18)]-fluoroethylcholine combined in-line PET-CT scan for detection of lymph-node metastasis in high risk prostate cancer patients prior to radical prostatectomy: Preliminary results from a prospective histology-based study

21 January 2018

1 reference

Noninvasive detection of clinically occult lymph-node metastases in prostate cancer

21 January 2018

1 reference

Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy

21 January 2018

1 reference

The detection rate of [11C]choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer.

21 January 2018

1 reference

[11C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy

21 January 2018

1 reference

[(11)C]choline PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy

21 January 2018

1 reference

Influence of trigger PSA and PSA kinetics on 11C-Choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy

21 January 2018

1 reference

Predictive factors of [(11)C]choline PET/CT in patients with biochemical failure after radical prostatectomy

21 January 2018

1 reference

Detection of local, regional, and distant recurrence in patients with psa relapse after external-beam radiotherapy using (11)C-choline positron emission tomography

21 January 2018

1 reference

[11C]Choline PET/CT detection of bone metastases in patients with PSA progression after primary treatment for prostate cancer: comparison with bone scintigraphy

21 January 2018

1 reference

Is there a role for ¹¹C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml?

21 January 2018

1 reference

The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer

21 January 2018

1 reference

Fluorocholine PET/CT in patients with prostate cancer: initial experience

21 January 2018

1 reference

[18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients.

21 January 2018

1 reference

Positron emission tomography/computed tomography with F-18-fluorocholine for restaging of prostate cancer patients: meaningful at PSA < 5 ng/ml?

21 January 2018

1 reference

The use of F-18 choline PET in the assessment of bone metastases in prostate cancer: correlation with morphological changes on CT.

21 January 2018

1 reference

Role of ¹⁸F-choline PET/CT in suspicion of relapse following definitive radiotherapy for prostate cancer

21 January 2018

1 reference

Role of 18F-choline PET/CT in biochemically relapsed prostate cancer after radical prostatectomy: correlation with trigger PSA, PSA velocity, PSA doubling time, and metastatic distribution

21 January 2018

1 reference

Clinical impact of 18F-choline PET/CT in patients with recurrent prostate cancer.

21 January 2018

1 reference

Choline PET or PET/CT and biochemical relapse of prostate cancer: a systematic review and meta-analysis

21 January 2018

1 reference

Diagnosis of local recurrence after radical prostatectomy.

21 January 2018

1 reference

Diagnostic efficacy of transrectal ultrasound-guided biopsy of the prostatic fossa in patients with rising PSA following radical prostatectomy

21 January 2018

1 reference

Role of 11C-choline PET/CT in the re-staging of prostate cancer patients with biochemical relapse and negative results at bone scintigraphy.

21 January 2018

1 reference

[(11)C]Choline positron emission tomography/computed tomography for staging and restaging of patients with advanced prostate cancer

21 January 2018

1 reference

The utility of 11C-choline PET/CT for imaging prostate cancer: a pictorial guide

21 January 2018

1 reference

PET/MR in prostate cancer: technical aspects and potential diagnostic value

21 January 2018

1 reference